Pay in 4 interest-free payments of $5.39 Learn more
Ships within 48 hours · Estimated delivery Oct 18 - Oct 23
Patients with SIBO residual symptoms and post-antibiotic gut dysbiosis in our Doral clinic have reported some of the most consistent early-phase results of any BPC-157 indication we prescribe for
We start with the dominant symptom, monitor response, and add therapies in a staged fashion, always weighing metabolic and oncologic risks
Getting this step right protects both your results and the integrity of the compound, since sloppy handling degrades the peptide and wastes money
Plan your draws to minimize punctures
Worsening symptoms, new weakness, or changes in bowel or bladder function require immediate medical attention regardless of any peptide protocol
